PDS Biotechnology Says Head, Neck Cancer Therapy Met Main Goal in Mid-Stage Study
PDS Biotechnology Says Head, Neck Cancer Therapy Met Main Goal in Mid-Stage Study
PDS Biotechnology表示，頭頸部癌症療法在中期研究中達到了主要目標
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊